EN CN


In Vitro Safety Assessment

Return

Kinase Panel Screening for Drug Discovery

Kinases, vital regulators in cellular signaling, are at the forefront of therapeutic research. Our Kinase Panel provides an essential tool for the early stages of drug discovery. It aids in identifying and evaluating the potential of kinase inhibitors, many of which have already gained FDA approval or are in clinical use. Our panels, including KinomeMINI, KinomeMED, KinomeMAX, and KinomeFULL, offer an unparalleled range of options to suit diverse research needs.


kpanel.jpg


Our Features

Comprehensive Coverage: : A broad spectrum of kinase targets, ensuring thorough analysis and evaluation.

State-of-the-Art Detection Techniques: Utilizing Homogeneous Time-Resolved Fluorescence (HTRF) and ADP-Glo assays for precise and reliable results.

Expertise and Precision:Our team of seasoned professionals guarantees accuracy and insightful analysis in functional kinase testing.

Speed and Flexibility: Rapid turnaround times, coupled with a flexible approach to cater to unique research demands.


Kinase Panel Screening Reference Data


1.jpg

This kinase inhibition dendrogram illustrates the inhibitory efficacy of BI-3406 at a concentration of 1µM across a spectrum of kinase families. The kinases are categorized into groups such as TK (Tyrosine Kinase), CMGC, AGC, CAMK, CK1, STE, and TKL, arranged according to their phylogenetic relationships. Kinases are marked with dots, where the color of each kinase indicates the level of inhibition achieved by BI-3406, with color coding as follows: red signifies 90-100% inhibition, yellow indicates 80-90%, blue represents 70-80%, and light blue denotes 50-70%. Green implies inhibition below 50%. This detailed visualization aids in identifying the selectivity profile of BI-3406, highlighting its potential therapeutic targets and off-target effects, which are critical for drug development and safety assessments.



Contact Us

We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.

We are a CRO service organization, not a hospital